Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Avacta, Aptamer,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Avacta, Aptamer,
Malawi Rail Upgrades Underway
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Advanced, Beacon,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Cirata, Echo,
It has just been announced that inflation has fallen from 3.2% to 2.3%, versus the 5.25% mortgage rate. Historically, mortgage rates have been either at or below the inflation rate.
Poolbeg Pharma (POLB), a biopharmaceutical company, said it has received the fully granted patent from the US Patent Office for its Immunomodulator II patent application.
Avacta Group (AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announced its preliminary results for the twelve months ending 31 December 2023.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Andrada, Cadence,
Visit First Class Metals at Booth #3300 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March
Sovereign Metals Limited (ASX:SVM; AIM:SVML) (the Company or Sovereign) is pleased to announce three senior appointments and promotions across key legal, permitting, and technical functions in Malawi. The appointments have strengthened the Company’s in-country
Everyone loves a good buyout. These are the companies from across the value chain that I think could be targets in 2024.
Ananda Developments (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines said it was pleased to announce the appointment of Professor Cherry Wainwright and Dr.